ATE403664T1 - Nukleinsäurekonstrukte und zellen, und verfahren zu deren verwendung zur modifikation der elektrophysiologischen funktion von erregbaren geweben - Google Patents
Nukleinsäurekonstrukte und zellen, und verfahren zu deren verwendung zur modifikation der elektrophysiologischen funktion von erregbaren gewebenInfo
- Publication number
- ATE403664T1 ATE403664T1 AT01967651T AT01967651T ATE403664T1 AT E403664 T1 ATE403664 T1 AT E403664T1 AT 01967651 T AT01967651 T AT 01967651T AT 01967651 T AT01967651 T AT 01967651T AT E403664 T1 ATE403664 T1 AT E403664T1
- Authority
- AT
- Austria
- Prior art keywords
- exactable
- tissues
- modify
- cells
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1329—Cardiomyocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/691,889 US7294333B1 (en) | 2000-10-20 | 2000-10-20 | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE403664T1 true ATE403664T1 (de) | 2008-08-15 |
Family
ID=24778375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01967651T ATE403664T1 (de) | 2000-10-20 | 2001-09-05 | Nukleinsäurekonstrukte und zellen, und verfahren zu deren verwendung zur modifikation der elektrophysiologischen funktion von erregbaren geweben |
Country Status (7)
Country | Link |
---|---|
US (2) | US7294333B1 (de) |
EP (3) | EP2385056B1 (de) |
AT (1) | ATE403664T1 (de) |
AU (1) | AU2001288019A1 (de) |
CA (1) | CA2426460A1 (de) |
DE (1) | DE60135237D1 (de) |
WO (1) | WO2002033111A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002019966A2 (en) * | 2000-09-06 | 2002-03-14 | Johns Hopkins University | Cardiac arrhythmia treatment methods |
US7491385B2 (en) * | 2001-09-05 | 2009-02-17 | Genegrafts Ltd. | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
CA2465476A1 (en) | 2001-11-08 | 2003-05-15 | The Regents Of The University Of California | Methods and compositions for correction of cardiac conduction disturbances |
WO2004030630A2 (en) | 2002-10-02 | 2004-04-15 | The Johns Hopkins University | Focal calcium channel modulation |
US20050002914A1 (en) * | 2003-01-15 | 2005-01-06 | Rosen Michael R. | Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
US20070021375A1 (en) | 2003-04-25 | 2007-01-25 | Vinod Sharma | Genetic modification of targeted regions of the cardiac conduction system |
US8013133B2 (en) * | 2003-04-25 | 2011-09-06 | Medtronic, Inc. | Genetic modification of targeted regions of the cardiac conduction system |
US20040214182A1 (en) * | 2003-04-25 | 2004-10-28 | Vinod Sharma | Genetic modification of targeted regions of the cardiac conduction system |
WO2005092033A2 (en) * | 2004-03-22 | 2005-10-06 | The Johns Hopkins University | Preventing arrhythmias associated with cell transplantation |
US7993906B2 (en) * | 2004-05-28 | 2011-08-09 | The Board Of Trustees Of The Leland Stanford Junior University | Closed-loop electrical stimulation system for cell cultures |
US8565898B2 (en) * | 2005-04-28 | 2013-10-22 | Medtronic, Inc. | Rate control during AF using cellular intervention to modulate AV node |
US9087368B2 (en) | 2006-01-19 | 2015-07-21 | The General Hospital Corporation | Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof |
EP2309221A1 (de) | 2006-02-24 | 2011-04-13 | The General Hospital Corporation | Verfahren und Systeme zur Durchführung von winkelaufgelöster optischer Kohärenztomografie im Fourier-Bereich |
US8838213B2 (en) | 2006-10-19 | 2014-09-16 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
WO2008078325A2 (en) * | 2006-12-27 | 2008-07-03 | Genegrafts Ltd. | A method of treating schizophrenia |
US20080280341A1 (en) * | 2007-05-08 | 2008-11-13 | Kenknight Bruce | System And Method For Local Field Stimulation |
US9150832B2 (en) * | 2007-05-08 | 2015-10-06 | Cardiac Pacemakers, Inc. | Cell training for local field stimulation |
US8311620B2 (en) * | 2007-08-22 | 2012-11-13 | Cardiac Pacemakers, Inc. | Methods and apparatus to treat and prevent atrial tachyarrhythmias |
US20110144028A1 (en) * | 2009-12-11 | 2011-06-16 | Vinod Sharma | Modulating cellular electrophysiology |
US8639323B2 (en) | 2010-11-01 | 2014-01-28 | Medtronic, Inc. | System and apparatus to monitor biopacemaker maturation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683912A (en) | 1994-07-21 | 1997-11-04 | The Salk Institute For Biological Studies | Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit |
US5602301A (en) * | 1993-11-16 | 1997-02-11 | Indiana University Foundation | Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
US5837220A (en) | 1995-09-19 | 1998-11-17 | Merck & Co., Inc. | Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig |
US5955259A (en) | 1996-12-19 | 1999-09-21 | Brandeis University | Method for assessing modulation of potassium ion channel activity |
US6110459A (en) | 1997-05-28 | 2000-08-29 | Mickle; Donald A. G. | Transplants for myocardial scars and methods and cellular preparations |
US6099832A (en) | 1997-05-28 | 2000-08-08 | Genzyme Corporation | Transplants for myocardial scars |
US5986081A (en) | 1997-10-22 | 1999-11-16 | Wisconsin Alumni Research Foundation | Polynucleotides encoding herg-3 |
US6913925B1 (en) * | 1998-08-12 | 2005-07-05 | Signal Pharmaceuticals Llc | Human mesencephalon cell lines and methods of use therefor |
WO2000018903A2 (en) * | 1998-09-29 | 2000-04-06 | The Johns Hopkins University | Inducible genetic suppression of cellular excitability |
WO2000043039A1 (en) * | 1999-01-22 | 2000-07-27 | Matthew John During | Vaccine-mediated treatment of neurological disorders |
ATE452988T1 (de) | 1999-04-15 | 2010-01-15 | Univ Utah Res Found | Mink-assoziierte gene, bildung von kalium-kanälen sowie assoziation zu herz-arrhytmien |
WO2002019966A2 (en) * | 2000-09-06 | 2002-03-14 | Johns Hopkins University | Cardiac arrhythmia treatment methods |
IL158618A0 (en) | 2001-04-27 | 2004-05-12 | Univ Johns Hopkins | Biological pacemaker |
-
2000
- 2000-10-20 US US09/691,889 patent/US7294333B1/en not_active Expired - Fee Related
-
2001
- 2001-09-05 AT AT01967651T patent/ATE403664T1/de not_active IP Right Cessation
- 2001-09-05 AU AU2001288019A patent/AU2001288019A1/en not_active Abandoned
- 2001-09-05 CA CA002426460A patent/CA2426460A1/en not_active Abandoned
- 2001-09-05 DE DE60135237T patent/DE60135237D1/de not_active Expired - Lifetime
- 2001-09-05 EP EP10181137.0A patent/EP2385056B1/de not_active Expired - Lifetime
- 2001-09-05 EP EP08160306A patent/EP2166017A1/de not_active Withdrawn
- 2001-09-05 US US10/399,715 patent/US20040029148A1/en not_active Abandoned
- 2001-09-05 WO PCT/IL2001/000833 patent/WO2002033111A2/en active IP Right Grant
- 2001-09-05 EP EP01967651A patent/EP1326879B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1326879B1 (de) | 2008-08-06 |
EP2385056A2 (de) | 2011-11-09 |
WO2002033111A3 (en) | 2002-12-19 |
EP1326879A2 (de) | 2003-07-16 |
WO2002033111A2 (en) | 2002-04-25 |
EP2385056B1 (de) | 2015-06-10 |
US7294333B1 (en) | 2007-11-13 |
EP2166017A1 (de) | 2010-03-24 |
EP2385056A3 (de) | 2012-02-01 |
DE60135237D1 (de) | 2008-09-18 |
AU2001288019A1 (en) | 2002-04-29 |
EP1326879A4 (de) | 2004-09-22 |
US20040029148A1 (en) | 2004-02-12 |
CA2426460A1 (en) | 2002-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE403664T1 (de) | Nukleinsäurekonstrukte und zellen, und verfahren zu deren verwendung zur modifikation der elektrophysiologischen funktion von erregbaren geweben | |
WO2004053079A3 (en) | Compositions, splice variants and methods relating to ovarian specific genes and proteins | |
DE60133472D1 (de) | Verfahren und vorrichtung zur herstellung von elektrodenplatten für zellen und diese elektrodenplatten verwendende zelle | |
DE60238493D1 (de) | Is von seltenen zellen verwendete markierte zellen | |
DE1100895T1 (de) | Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts | |
ES2180782T3 (es) | Procedimiento para la identificacion o el aislamiento de una molecula y moleculas identificadas de ese modo. | |
DE60140773D1 (de) | Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS) | |
DE69819124D1 (de) | Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna | |
WO2007027315A3 (en) | A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE69811348T2 (de) | Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen | |
DE60044350D1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
ATE476999T1 (de) | Vegf und hgf exprimierenden nukleinsäurekonstrukte, damit transformierte zellen und dieser verwendung zur induzierung der leberregeneration und linderung von pfortaderhochdruck | |
TR200201119T2 (tr) | İnsan alfa1G-C-türü kalsiyum kanalı kodlayan DNA. | |
DE60023691D1 (de) | T-bet zusammensetzungen und deren vervendungsmethoden | |
WO2004053075A3 (en) | Compositions, splice variants and methods relating to breast specific genes and proteins | |
DE60238810D1 (de) | Rekombinante D-Hydantoin Hydrolasen und N-Carbamyl-Aminosäure Amid Hydrolasen, dafür kodierende DNA; deren Verwendung zur Herstellung von D-Aminosäuren | |
WO2004050860A3 (en) | Compositions, splice variants and methods relating to colon specific genes and proteins | |
ATE525356T1 (de) | 2,5-diaminopyridin oxidationsbasen, deren verwendung zur färbung von keratinischen fasern | |
WO2004013311A3 (en) | Compositions and methods relating to ovarian specific genes and proteins | |
DE69531505D1 (de) | Verfahren zur zellerkennung | |
ATE320284T1 (de) | Verwendung von mindestens einem derivat der 10- hydroxy-2-decenoicsäure in einer zusammensetzung zur förderung der abschuppung der haut | |
ATE407944T1 (de) | Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz | |
WO2003066877A3 (en) | Compositions and methods relating to hepatic specific genes and proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |